Opportunity Information: Apply for PA 15 177

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273 Alcohol Research Programs 93.279 Drug Abuse and Addiction Research Programs.
  • This funding opportunity was created on Apr 7, 2015 and posted on Apr 7, 2015.
  • Applicants must submit their applications by May 7, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Public housing authorities/Indian housing authorities State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education City or township governments County governments For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Special district governments Independent school districts Others (see text field entitled Additional Information on Eligibility for clarification).
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PA 15 177

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34) opportunity (Funding Opportunity Number PA 15 177) is a National Institutes of Health (NIH) discretionary grant program designed to fund early, proof-building research that helps teams get ready for larger, full scale prevention trials. The core purpose is to support pilot and feasibility studies that generate the preliminary evidence and practical know how needed before submitting a subsequent, larger application for drug or alcohol abuse prevention and/or drug or alcohol related HIV prevention intervention research. In other words, this R34 is meant to help investigators test whether a prevention approach is workable, acceptable, and promising enough to justify a bigger, more definitive study.

The FOA emphasizes two main research directions. First, it supports pilot and feasibility testing of innovative prevention interventions that are new, revised, or adapted for specific populations or settings. These interventions should aim to prevent or delay the initiation of drug and alcohol use, prevent escalation from early use to problematic use, and reduce progression to alcohol or other substance use disorders. It also includes prevention efforts focused on reducing drinking and driving and deaths associated with impaired driving, as well as interventions intended to reduce drug or alcohol related acquisition or transmission of HIV infection and viral hepatitis. A key theme is relevance across diverse populations and real world settings, with explicit interest in interventions that target or are delivered through the healthcare system.

Second, the FOA supports pre trial feasibility testing for prevention services and systems research. This is aimed at questions that come up when prevention strategies have to function inside service systems, such as healthcare delivery organizations, community programs, schools, justice related settings, or other prevention infrastructures. Under this scope, applicants might focus on whether an approach can be implemented reliably, whether organizations can deliver it with fidelity, whether workflows and staffing models can support it, how clients engage with it, and what operational or system level barriers need to be addressed before launching a full trial.

A central expectation of the R34 mechanism here is that the work will produce early stage efficacy, effectiveness, or services research evidence. That typically means collecting the kind of preliminary outcome and implementation data that demonstrates an intervention is feasible to deliver, acceptable to participants and providers, and sufficiently promising to justify investment in a larger scale study. The FOA frames these pilot data as a prerequisite for preparing and submitting later applications for more expansive prevention intervention trials, so the R34 is positioned as a stepping stone between idea development and a full powered evaluation.

At the same time, the FOA draws a clear boundary around what it will not fund. It does not support applications where the only activity is developing intervention protocols, manuals, or standardizing procedures. Development work can be part of the project, but only if it is embedded within an actual pilot or feasibility study that tests the approach in practice. The point is not to produce materials on paper alone, but to demonstrate through real world testing that the intervention and study procedures can function as intended.

From an administrative standpoint, this is an NIH grant in the health and education related research space, tied to CFDA program areas 93.273 (Alcohol Research Programs) and 93.279 (Drug Abuse and Addiction Research Programs). There is no cost sharing or matching requirement listed, which generally means applicants are not required to contribute non federal funds as a condition of the award. The FOA was posted April 7, 2015, with an original and current closing date of May 7, 2018, and an archive date of June 7, 2018, indicating the announcement is no longer active for new submissions under that specific posting, though similar NIH FOAs may exist in later versions.

Eligibility is broad and includes many types of organizations that might be positioned to conduct prevention research. Eligible applicants include state, county, city or township, and special district governments; public and state controlled institutions of higher education; private institutions of higher education; independent school districts; public housing authorities; nonprofits with and without 501(c)(3) status; for profit organizations (other than small businesses); and small businesses. It also includes Native American tribal governments (federally recognized), tribal organizations (other than federally recognized governments), and a range of mission focused institutions and community entities such as faith based or community based organizations, Historically Black Colleges and Universities (HBCUs), Hispanic serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, and Asian American Native American Pacific Islander serving institutions (AANAPISIs). The eligibility language also allows non U.S. entities (foreign organizations), U.S. territories or possessions, regional organizations, and eligible federal agencies, reflecting NIHs interest in scientifically strong prevention research across varied contexts.

For applicants seeking more detail, the FOA points to the full announcement on the NIH grants site (http://grants.nih.gov/grants/guide/pa-files/PA-15-177.html). For technical issues accessing or linking to the announcement, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.

Frequently Asked Questions (FAQs)

What is the Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34) opportunity?

This opportunity (Funding Opportunity Number PA 15 177) is an NIH discretionary grant program that funds early, proof-building research. Its purpose is to support pilot and feasibility studies that help research teams prepare for larger, full-scale drug and alcohol abuse prevention trials (including drug/alcohol-related HIV prevention intervention research).

What is the main goal of this R34 FOA?

The main goal is to generate preliminary evidence and practical, real-world know-how showing that a prevention approach is workable, acceptable, and promising enough to justify a subsequent, larger application for a full-powered prevention intervention trial.

What kinds of studies does this FOA support?

The FOA supports pilot and feasibility studies that produce early-stage efficacy, effectiveness, or services research evidence. This typically includes preliminary outcome and implementation information demonstrating feasibility of delivery, acceptability to participants and/or providers, and sufficient promise to warrant a larger trial.

What are the two main research directions emphasized by the FOA?

The FOA highlights two directions: (1) pilot and feasibility testing of innovative prevention interventions (new, revised, or adapted for specific populations or settings), and (2) pre-trial feasibility testing for prevention services and systems research focused on how prevention strategies function within real service systems.

What prevention outcomes or targets are within scope?

Within scope are interventions intended to prevent or delay initiation of drug and alcohol use, prevent escalation from early use to problematic use, and reduce progression to alcohol or other substance use disorders. The FOA also includes prevention efforts focused on reducing drinking and driving and deaths associated with impaired driving, as well as interventions intended to reduce drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis.

Does the FOA encourage research in particular settings?

Yes. A key theme is relevance across diverse populations and real-world settings, with explicit interest in interventions that target or are delivered through the healthcare system.

What does "innovative prevention interventions" mean in this FOA?

Based on the FOA description provided, it includes interventions that are new, revised, or adapted for specific populations or settings and then tested in a pilot or feasibility study to determine whether they are workable, acceptable, and promising.

What is meant by "prevention services and systems research" in this FOA?

This refers to feasibility questions that arise when prevention strategies must operate inside service systems (such as healthcare delivery organizations, community programs, schools, justice-related settings, or other prevention infrastructures). The focus is on whether an approach can be implemented reliably, delivered with fidelity, supported by workflows and staffing models, and engaged with by clients, and what system-level barriers must be addressed before a full trial.

What kinds of feasibility questions can be addressed under the services and systems focus?

Examples mentioned include whether the approach can be implemented reliably, whether organizations can deliver it with fidelity, whether workflows and staffing models can support it, how clients engage with it, and what operational or system-level barriers need to be addressed prior to launching a full trial.

What is the expected "stepping stone" role of this R34 mechanism?

The R34 is positioned between idea development and a full-powered evaluation. It is intended to produce pilot data that serve as a prerequisite for preparing and submitting later applications for larger, more expansive prevention intervention trials.

What does the FOA say about early-stage evidence requirements?

The FOA describes an expectation that the work will produce early-stage efficacy, effectiveness, or services research evidence, typically by collecting preliminary outcome and implementation data demonstrating feasibility, acceptability, and promise.

What will this FOA not fund?

The FOA draws a clear boundary: it does not support applications where the only activity is developing intervention protocols, manuals, or standardizing procedures. Development work may be included only if it is embedded within an actual pilot or feasibility study that tests the approach in practice.

Can intervention development be part of an R34 project under this FOA?

Yes, but only as part of an actual pilot or feasibility study that tests the approach in practice. The FOA emphasizes that the goal is not to produce materials alone, but to demonstrate through real-world testing that the intervention and study procedures can function as intended.

Is this a mandatory cost sharing or matching program?

No cost sharing or matching requirement is listed. This generally means applicants are not required to contribute non-federal funds as a condition of the award (based on the information provided).

Which NIH/health research program areas are associated with this FOA (CFDA)?

The FOA is tied to CFDA program areas 93.273 (Alcohol Research Programs) and 93.279 (Drug Abuse and Addiction Research Programs).

When was this FOA posted and when did it close?

The FOA was posted on April 7, 2015. The original and current closing date listed is May 7, 2018, with an archive date of June 7, 2018.

Is this FOA still active for new submissions?

No. The closing and archive dates indicate the announcement is no longer active for new submissions under that specific posting, although similar NIH FOAs may exist in later versions.

Who is eligible to apply?

Eligibility is broad and includes: state, county, city or township, and special district governments; public and state controlled institutions of higher education; private institutions of higher education; independent school districts; public housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses.

Are tribal entities and mission-focused institutions eligible?

Yes. Eligible applicants include Native American tribal governments (federally recognized) and tribal organizations (other than federally recognized governments). The list also includes faith-based or community-based organizations, HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, and AANAPISIs.

Are non-U.S. organizations eligible to apply?

Yes. The eligibility language allows non-U.S. entities (foreign organizations), U.S. territories or possessions, regional organizations, and eligible federal agencies.

Where can applicants find the full FOA text?

The FOA points to the full announcement on the NIH grants site at http://grants.nih.gov/grants/guide/pa-files/PA-15-177.html

Who should be contacted for technical issues accessing or linking to the announcement?

For technical issues accessing or linking to the announcement, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Census of Tribal Law Enforcement Agencies

Previous opportunity: OSERS/RSA Vocational Rehabilitation Services Projects for American Indians with Disabilities CFDA Number 84.250K

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 15 177

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 15 177) also looked into and applied for these:

Funding Opportunity
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34) Apply for PA 15 250

Funding Number: PA 15 250
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $225,000
Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01) Apply for PA 15 251

Funding Number: PA 15 251
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R03) Apply for PA 15 252

Funding Number: PA 15 252
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $50,000
Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R21) Apply for PA 15 253

Funding Number: PA 15 253
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Development of Measures of Fatigability in Older Adults (R21) Apply for RFA AG 16 013

Funding Number: RFA AG 16 013
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Provocative Questions in Cancer with an Underlying HIV Infection (R21) Apply for RFA CA 15 013

Funding Number: RFA CA 15 013
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Provocative Questions (PQ) Initiative Cancer with an Underlying HIV Infection (R01) Apply for RFA CA 15 012

Funding Number: RFA CA 15 012
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Clinical and Translational Science Award (CTSA) Network Recruitment Innovation Centers (RICs)(U24) Apply for RFA TR 15 004

Funding Number: RFA TR 15 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $2,000,000
Assay Validation For High Quality Markers For NCI Supported Clinical Trials (Admin Supp) Apply for PA 15 264

Funding Number: PA 15 264
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $150,000
Martin Delaney Collaboratories for HIV Cure Research (UM1) Apply for RFA AI 15 029

Funding Number: RFA AI 15 029
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $3,500,000
Oncology Co Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24) Apply for PAR 15 266

Funding Number: PAR 15 266
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Fast Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3) Apply for PAR 15 267

Funding Number: PAR 15 267
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $1,000,000
Harnessing Genome Editing Technologies to Functionally Validate Genetic Variants in Substance Use Disorders (R21/R33) Apply for RFA DA 16 004

Funding Number: RFA DA 16 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Tools and Services for Designing Methodologically Rigorous Animal Studies (R41/R42) Apply for RFA DA 16 002

Funding Number: RFA DA 16 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Tools and Services for Designing Methodologically Rigorous Animal Studies (R43/R44) Apply for RFA DA 16 003

Funding Number: RFA DA 16 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Career Development Program in Emergency Care Research (K12) Apply for RFA HL 16 019

Funding Number: RFA HL 16 019
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Harnessing Big Data to Halt HIV (R01) Apply for PA 15 273

Funding Number: PA 15 273
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Smoking Cessation within the Context of Lung Cancer Screening (R01) Apply for RFA CA 15 011

Funding Number: RFA CA 15 011
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R01) Apply for PAR 15 274

Funding Number: PAR 15 274
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R21) Apply for PAR 15 275

Funding Number: PAR 15 275
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 15 177", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.